(VIANEWS) – CVB Financial Corporation (CVBF), Supernus Pharmaceuticals (SUPN), Timken Steel Corporation (TMST) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. CVB Financial Corporation (CVBF)

22.3% sales growth and 9.48% return on equity

CVB Financial Corp. is a bank holding firm for Citizens Business Bank. Citizens Business Bank is a state-chartered banking institution that offers financial and banking services to individuals and small businesses.

CVB Financial Corporation’s sales growth this year is anticipated to be 18% and 12.4% for next year.

Year-on-year quarterly revenue growth declined by 9.1%, now sitting on 471.48M for the twelve trailing months.

Volume

Today’s last reported volume for CVB Financial Corporation is 1589070 which is 63.78% above its average volume of 970245.

CVB Financial Corporation’s sales growth for the next quarter is 22.3%. The company’s growth estimates for the current quarter and the next is a negative 0% and 13.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.48%.

Volatility

CVB Financial Corporation’s last day, last week, and last month’s current intraday variation average was 1.93%, 1.47%, and 0.97%, respectively.

CVB Financial Corporation’s highest amplitude of average volatility was 2.26% (day), 2.15% (last week), and 2.02% (last month), respectively.

CVB Financial Corporation’s Stock Yearly Top and Bottom Value

CVB Financial Corporation’s stock is valued at $24.76 at 16:22 EST, under its 52-week high of $25.22 and way higher than its 52-week low of $18.72.

CVB Financial Corporation’s Moving Average

CVB Financial Corporation’s value is higher than its 50-day moving average of $23.95 and way above its 200-day moving average of $22.18.

2. Supernus Pharmaceuticals (SUPN)

17.5% sales growth and 9.27% return on equity

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm that focuses on developing and marketing products to treat central nervous system disorders in the United States.

Supernus Pharmaceuticals’s sales growth this year is anticipated to be 16.2% and a negative 14.5% for next year.

Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 601.35M for the twelve trailing months.

Volume

Today’s last reported volume for Supernus Pharmaceuticals is 354253 which is 18.39% below its average volume of 434120.

Supernus Pharmaceuticals’s sales growth for the next quarter is 17.5%. The company’s growth estimates for the current quarter and the next is a negative 32.6% and negative -5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.27%.

Volatility

Supernus Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 2.08%, 1.42%, and 1.70%, respectively.

Supernus Pharmaceuticals’s highest amplitude of average volatility was 5.55% (day), 3.91% (last week), and 3.49% (last month), respectively.

Supernus Pharmaceuticals’s Stock Yearly Top and Bottom Value

Supernus Pharmaceuticals’s stock is valued at $28.99 at 16:22 EST, way below its 52-week high of $34.50 and way higher than its 52-week low of $23.15.

Supernus Pharmaceuticals’s Moving Average

Supernus Pharmaceuticals’s worth is higher than its 50-day moving average of $27.91 and below its 200-day moving average of $29.69.

3. Timken Steel Corporation (TMST)

14.4% sales growth and 29.18% return on equity

TimkenSteel Corporation produces and sells alloy steel and carbon- and micro-alloys steel products throughout the United States as well as internationally.

Timken Steel Corporation’s sales growth this year is anticipated to be 16.2% and 1.2% for next year.

Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 1.28B for the twelve trailing months.

Volume

Today’s last reported volume for Timken Steel Corporation is 879174 which is 15.21% above its average volume of 763096.

Timken Steel Corporation’s sales growth for the next quarter is 14.4%. The company’s growth estimates for the present quarter and the next is 42.7% and 14.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.18%.

Volatility

Timken Steel Corporation’s last day, last week, and last month’s current intraday variation average was 2.79%, 3.42%, and 3.70%, respectively.

Timken Steel Corporation’s highest amplitude of average volatility was 6.73% (day), 6.37% (last week), and 5.72% (last month), respectively.

Timken Steel Corporation’s Stock Yearly Top and Bottom Value

Timken Steel Corporation’s stock is valued at $19.23 at 16:22 EST, way under its 52-week high of $26.23 and way higher than its 52-week low of $11.68.

Timken Steel Corporation’s Moving Average

Timken Steel Corporation’s value is way under its 50-day moving average of $21.51 and way higher than its 200-day moving average of $17.27.

4. MVB Financial Corp. (MVBF)

13.9% sales growth and 13.31% return on equity

MVB Financial Corp. and its subsidiaries offer banking and mortgage services to Americans and corporations.

MVB Financial Corp.’s sales growth this year is anticipated to be 10.5% and 31.7% for next year.

Year-on-year quarterly revenue growth grew by 10.5%, now sitting on 138.34M for the twelve trailing months.

Volume

Today’s last reported volume for MVB Financial Corp. is 70811 which is 94.53% above its average volume of 36400.

MVB Financial Corp.’s sales growth for the next quarter is 13.9%. The company’s growth estimates for the ongoing quarter and the next is a negative 53.4% and negative -47.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.31%.

Volatility

MVB Financial Corp.’s last day, last week, and last month’s current intraday variation average was 3.38%, 1.56%, and 1.46%, respectively.

MVB Financial Corp.’s highest amplitude of average volatility was 3.93% (day), 3.23% (last week), and 2.77% (last month), respectively.

MVB Financial Corp.’s Stock Yearly Top and Bottom Value

MVB Financial Corp.’s stock is valued at $32.16 at 16:22 EST, way under its 52-week high of $44.36 and above its 52-week low of $30.56.

MVB Financial Corp.’s Moving Average

MVB Financial Corp.’s worth is way under its 50-day moving average of $36.47 and way under its 200-day moving average of $40.03.

5. Oxford Square Capital Corp. (OXSQ)

5.1% sales growth and 4.05% return on equity

Oxford Square Capital Corp., a business development firm, is an investment and management company that operates in a closed-end non-diversified market.

Oxford Square Capital Corp.’s sales growth this year is anticipated to be 9.5% and 12% for next year.

Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 37.68M for the twelve trailing months.

Volume

Today’s last reported volume for Oxford Square Capital Corp. is 182359 which is 11.43% below its average volume of 205898.

Oxford Square Capital Corp.’s sales growth for the next quarter is 5.1%. The company’s growth estimates for the ongoing quarter and the next is 33.3% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.05%.

Oxford Square Capital Corp.’s Stock Yearly Top and Bottom Value

Oxford Square Capital Corp.’s stock is valued at $3.64 at 16:22 EST, way below its 52-week high of $5.00 and above its 52-week low of $3.45.

Oxford Square Capital Corp.’s Moving Average

Oxford Square Capital Corp.’s worth is below its 50-day moving average of $3.94 and way below its 200-day moving average of $4.08.

LEAVE A REPLY

Please enter your comment!
Please enter your name here